Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire June 26, 2024 at 07:30 AM EDT MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below. CONFERENCE CALL INFORMATIONConference Call DateJuly 10, 2024Conference Call Time8:30 a.m. ETWebcast linkhttps://edge.media-server.com/mmc/p/4mkgkywoDial in1-888-513-4119 (toll free) or 1-412-902-6615 (international)Access Code0474907CONFERENCE CALL REPLAYToll Free1-877-344-7529 (US) / 1-855-669-9658 (Canada)International Toll1-412-317-0088Replay Access Code4477930Replay End DateJuly 17, 2024To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries: Philippe Dubuc Senior Vice President and Chief Financial Officer pdubuc@theratech.com 438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire June 26, 2024 at 07:30 AM EDT MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below. CONFERENCE CALL INFORMATIONConference Call DateJuly 10, 2024Conference Call Time8:30 a.m. ETWebcast linkhttps://edge.media-server.com/mmc/p/4mkgkywoDial in1-888-513-4119 (toll free) or 1-412-902-6615 (international)Access Code0474907CONFERENCE CALL REPLAYToll Free1-877-344-7529 (US) / 1-855-669-9658 (Canada)International Toll1-412-317-0088Replay Access Code4477930Replay End DateJuly 17, 2024To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries: Philippe Dubuc Senior Vice President and Chief Financial Officer pdubuc@theratech.com 438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800
MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below. CONFERENCE CALL INFORMATIONConference Call DateJuly 10, 2024Conference Call Time8:30 a.m. ETWebcast linkhttps://edge.media-server.com/mmc/p/4mkgkywoDial in1-888-513-4119 (toll free) or 1-412-902-6615 (international)Access Code0474907CONFERENCE CALL REPLAYToll Free1-877-344-7529 (US) / 1-855-669-9658 (Canada)International Toll1-412-317-0088Replay Access Code4477930Replay End DateJuly 17, 2024To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries: Philippe Dubuc Senior Vice President and Chief Financial Officer pdubuc@theratech.com 438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800